UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000018412 |
|---|---|
| Receipt number | R000021317 |
| Scientific Title | Research on biomarkers in "A randomized phase II study to investigate the deepness of response of FOLFOXIRI plus cetuximab (Erbitux) versus FOLFOXIRI plus bevacizumab as the first-line therapy in metastatic colorectal cancer patients with RAS wild-type tumors" |
| Date of disclosure of the study information | 2015/07/27 |
| Last modified on | 2020/07/21 10:29:59 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/07/24 15:02:42 | ||
| 2 | Update | 2015/07/30 14:15:03 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
| 3 | Update | 2016/11/15 14:00:28 | Name of primary person or sponsor Organization |
|
| 4 | Update | 2020/07/21 10:28:03 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel Institutions |
|
| 5 | Update | 2020/07/21 10:28:59 | Recruitment status Date of IRB Last follow-up date |
|
| 6 | Update | 2020/07/21 10:29:59 | Number of participants that the trial has enrolled |
